GERD Drugs and Devices Market has recently added a report Forecast to 2027 to its repository, which comprises of data relating to the market size, share, value, and volume, production processes, revenue generation, the regional analysis of the business vertical, along with the outcomes of analytical tools including, SWOT analysis and Porter’s Five Forces analysis. The report highlights the growth opportunities and challenges that industry players might encounter in the forecast years, along with an elaborate competitive landscape and expansion strategies adopted by the companies functioning in the Keyword Market.

Get a Free sample of the report : https://www.emergenresearch.com/request-sample/383

Gastroesophageal Reflux Disease is growing due to the intake of analgesics, smoking, decrease in the prevalence of Helicobacter pylori infection, consumption of certain types of food and drinks, high body mass index (BMI), family history of GERD, and limited physical activity. The growing incidence of the disease will drive the demand for the GERD drug and devices market.The expiration of the patent on most of the drugs is paving the way for new over the counter and generic drugs. The poor reimbursement of procedures and devices, low safety, and efficacy are restricting the adoption of the GERD drugs and devices market.

The report is updated with the latest economic scenario and market scope with regard to the ongoing COVID-19 pandemic. The report covers growth prospects as well as current and futuristic revenue estimations in a post COVID scenario. The report also covers changing trends and market dynamics due to the pandemic and provides an accurate impact analysis of the crisis on the overall market.

The MUSE or Medigus Ultrasonic Surgical Endostapler is an extensive endoscopic device that incorporates the latest technological advancement for the delivery of patient-friendly option for Transoral Fundoplication, the procedure intended for the treatment of GERD.

North America held the largest share, with the U.S. contributing the major revenue share. The rise in the geriatric population in the region, which is prone to acid reflux and development in heartburn, will drive the demand of the Gastroesophageal Reflux Disease Drugs and Devices market

Key participants include Johnson & Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Merck & CO., Inc., Boston Scientific Corporation, Eisai Co., Ltd., and Ironwood Pharmaceuticals, Inc., among others.

For the purpose of this report, Emergen Research has segmented into the global GERD Drugs and Devices Market on the basis of route of administration, drug type, device type, and region:

Route Of Administration Outlook (Revenue, USD Billion; 2017-2027)

• Oral
• Parenteral

Drug Type Outlook (Revenue, USD Billion; 2017-2027)

• H2 Receptor Antagonist
• Proton Pump Inhibitor (PPIs)
• Antacids

Device Type Outlook (Revenue, USD Billion; 2017-2027)

• MUSE –Medigus Ultrasonic Surgical Endostapler
• LINX Management System
• Stretta Therapy
• Bravo Reflux Testing System
• Digitrapper reflux testing system
• Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

• North America
  1. U.S.
  2. Canada
• Europe
  1. Germany
  2. UK
  3. France
  4. BENELUX
  5. Rest of Europe
• Asia Pacific
  1. China
  2. Japan
  3. South Korea
  4. Rest of APAC
• Latin America
  1. Brazil
  2. Rest of LATAM
• MEA
  1. Saudi Arabia
  2. UAE
  3. Rest of MEA

Request customization of the report: https://www.emergenresearch.com/request-for-customization/383

Market Taxonomy:

Chapter 1: Methodology & Scope

• Definition and forecast parameters
• Methodology and forecast parameters
• Data Sources

Chapter 2:

Executive Summary

• Business trends
• Regional trends
• Product trends
• End-use trends

Chapter 3:

Industry Insights

• Industry segmentation
• Industry landscape
• Vendor matrix
• Technological and innovation landscape

Chapter 4:

Regional Landscape

Chapter 5:

Company Profile

• Business Overview
• Financial Data
• Product Landscape
• Strategic Outlook

Global GERD Drugs and Devices Market Geographical Landscape - Synopsis:

The report closely studies the growth trajectory of the global GERD Drugs and Devices market. It brings to light the global dominance of the leading regional segments, including North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

The study elaborates on the crucial information pertaining to the regional market share. It simultaneously focuses on the significant details about the growth patterns of each regional market.

Moreover, the report encases an exhaustive geographical study of the market, emphasizing the business growth prospects and market barriers for each of the key market regions.

Read More: https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market

Related reports:

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs